Leniolisib: a novel treatment for activated phosphoinositide-3 kinase delta syndrome.

MLA

De, Surya K. “Leniolisib: A Novel Treatment for Activated Phosphoinositide-3 Kinase Delta Syndrome.” Frontiers in Pharmacology, vol. 15, Feb. 2024, p. 1337436. EBSCOhost, https://doi.org/10.3389/fphar.2024.1337436.

APA

De, S. K. (2024). Leniolisib: a novel treatment for activated phosphoinositide-3 kinase delta syndrome. Frontiers in Pharmacology, 15, 1337436. https://doi.org/10.3389/fphar.2024.1337436

Chicago

De, Surya K. 2024. “Leniolisib: A Novel Treatment for Activated Phosphoinositide-3 Kinase Delta Syndrome.” Frontiers in Pharmacology 15 (February): 1337436. doi:10.3389/fphar.2024.1337436.